Germany's diabetes medicine sales are projected to increase steadily from $4.11 billion in 2024 to $4.49 billion in 2028. This represents a Compound Annual Growth Rate (CAGR) over the five-year period. The market saw a gradual increase from the base year in 2023, indicating constant growth momentum bolstered by rising diabetes prevalence and advancements in treatment options.

Future trends to watch for include:

Increasing adoption of innovative diabetes management technologies and therapeutics.
Heightened awareness and early diagnosis leading to higher demand for medications.
Potential regulatory changes affecting pricing and market access.